Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 18,383 | 69,350 | 56,555 | 41,626 | 22,469 |
| Depreciation Amortization | 5,224 | 21,410 | 16,158 | 10,733 | 5,606 |
| Income taxes - deferred | 3,557 | -7,183 | -8,314 | -6,825 | 3,667 |
| Accounts payable and accrued liabilities | -246 | -2,656 | -2,742 | -3,711 | -2,153 |
| Other Working Capital | -20,223 | 771 | -10,913 | -18,033 | -15,221 |
| Other Operating Activity | 6,138 | 22,210 | 12,695 | 10,524 | 5,333 |
| Operating Cash Flow | $12,833 | $103,902 | $63,439 | $34,314 | $19,701 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,107 | -10,393 | -7,111 | -3,532 | -1,786 |
| Net Acquisitions | N/A | -6,532 | -6,532 | -6,532 | N/A |
| Other Investing Activity | -1,271 | 4,555 | 4,555 | 4,555 | 0 |
| Investing Cash Flow | $-3,378 | $-12,370 | $-9,088 | $-5,509 | $-1,786 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 11,000 | 11,000 | 10,500 | 10,000 |
| Common Stock Repurchased | 0 | -25,382 | -25,382 | -25,382 | -25,382 |
| Other Financing Activity | -3,199 | -15,706 | -15,556 | -15,012 | -4,211 |
| Financing Cash Flow | $-3,199 | $-30,088 | $-29,938 | $-29,894 | $-19,593 |
| Exchange Rate Effect | 790 | -13,777 | -17,702 | -8,535 | -403 |
| Beginning Cash Position | 291,320 | 243,653 | 243,653 | 243,653 | 243,653 |
| End Cash Position | 298,366 | 291,320 | 250,364 | 234,029 | 241,572 |
| Net Cash Flow | $7,046 | $47,667 | $6,711 | $-9,624 | $-2,081 |
| Free Cash Flow | |||||
| Operating Cash Flow | 12,833 | 103,902 | 63,439 | 34,314 | 19,701 |
| Capital Expenditure | -2,107 | -10,400 | -7,115 | -3,535 | -1,789 |
| Free Cash Flow | 10,726 | 93,502 | 56,324 | 30,779 | 17,912 |